Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2022 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
API - Small Molecule
16 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Parenteral Drug Products
Innovating to Optimize Quality in Injectable Drugs
PAO-11-022-CL-16
Olon, International API Supplier, Releases New 2022 Sustainability Report
PR-M11-22-08
Particle Engineering
Addressing Poor API Solubility with Comprehensive Particle Engineering Technology
PAO-11-022-CL-08
CDMO
Looking to Another 50 Years of Growth
PAO-02-22-R250-01
Market Prediction
Global Endometrial Cancer Therapeutics Markets 2018-2022 - Increase in Small Molecules in Drug Development Pipeline
PR-M10-18-NI-004
Small Molecule
New Small-Molecule Drugs Could Enhance Immune Responses to Cancer
PAO-M09-18-NI-020
Small Molecule
SwRI to host 2018 small molecule drug development workshop
PR-M08-18-NI-112
FDA Approval
Ironshore Pharmaceuticals Announces FDA Approval of JORNAY PMTM(Methylphenidate) Extended-Release Capsules CII for the Treatment of ADHD
PR-M08-18-NI-101
Drug Development
Synspira’s PAAG Therapy Demonstrates Persistence Against Pseudomonas aeruginosa Persister Cells
PR-M08-18-NI-100
Oral Solid Dose
HPAPIs and Two-Piece Liquid-Fill Capsules: The Perfect Match
PAO-06-18-CL-001
Solid Oral Dosage Drugs
Experience Meets Flexibility
PAP-Q2-18-CL-016
FDA
New WuXi STA Solid-Dose API Plant Gets Okay from US FDA
PAO-M05-18-NI-004
Drug Development
Sosei Regains Worldwide Rights from Teva to Develop and Commercialize Novel Small Molecule CGRP Antagonists for Migraine and Other Severe Headaches
PR-M03-18-NI-054
Innovation
Single-Pill, HIV-1 Combination Therapy Approved
PAO-M11-17-NI-050
Discovery
Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration
PAO-M11-17-NI-049
NIH Funds Novel Small Molecule Approach to Interrupt Alzheimer’s Dementia
PAO-M10-17-NI-003
